- Home
- Publications
- Publication Search
- Publication Details
Title
Non‐small cell lung cancer in China
Authors
Keywords
-
Journal
Cancer Communications
Volume 42, Issue 10, Pages 937-970
Publisher
Wiley
Online
2022-09-09
DOI
10.1002/cac2.12359
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Asbestos‐related lung cancer: Clinical characteristics and survival outcomes in an Australian cohort seeking workers compensation
- (2022) Rebecca A Hyland et al. Asia-Pacific Journal of Clinical Oncology
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)
- (2022) Sai-Hong Ignatius Ou et al. JOURNAL OF CLINICAL ONCOLOGY
- Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial
- (2022) Caicun Zhou et al. LANCET ONCOLOGY
- Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
- (2022) Qing Zhou et al. LANCET ONCOLOGY
- Indoor Air Pollution Increases the Risk of Lung Cancer
- (2022) Ke-Cheng Chen et al. International Journal of Environmental Research and Public Health
- Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
- (2022) Howard Jack West et al. Journal for ImmunoTherapy of Cancer
- 85P Adjuvant osimertinib in patients (pts) with stage IB–IIIA EGFR mutation-positive (EGFRm) NSCLC after complete tumour resection: ADAURA China subgroup analysis
- (2022) W. Jie et al. ANNALS OF ONCOLOGY
- Prediction of lung cancer risk based on age and smoking history
- (2022) Jason H.T. Bates et al. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
- Perioperative comparison of video-assisted thoracic surgery and open lobectomy for pT1-stage non-small cell lung cancer patients in China: a multi-center propensity score-matched analysis
- (2021) Jinming Xu et al. Translational Lung Cancer Research
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic impact of KRAS G12C mutation in patients with NSCLC: results from the ETOP Lungscape Project
- (2021) Stephen P. Finn et al. Journal of Thoracic Oncology
- Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study
- (2021) Ying Cheng et al. Targeted Oncology
- Asthma and asthma symptom control in relation to incidence of lung cancer in the HUNT study
- (2021) Lin Jiang et al. Scientific Reports
- Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy
- (2021) Stefano Trebeschi et al. Frontiers in Oncology
- Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
- (2021) Jin Kang et al. Cancer Communications
- Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
- (2021) Wei Cao et al. CHINESE MEDICAL JOURNAL
- Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
- (2021) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study
- (2021) Sebastian-Edgar Baumeister et al. Journal of Thoracic Oncology
- Lung Cancer in Republic of China
- (2021) Yung-Hung Luo et al. Journal of Thoracic Oncology
- PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis
- (2021) J. Lee et al. Journal of Thoracic Oncology
- Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC
- (2021) Tianqing Chu et al. Journal of Thoracic Oncology
- Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study
- (2021) Yuankai Shi et al. Lancet Respiratory Medicine
- The Prevalence and Concurrent Pathogenic Mutations of KRASG12C in Northeast Chinese Non-small-cell Lung Cancer Patients
- (2021) Yan Liu et al. Cancer Management and Research
- Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
- (2021) Jie Wang et al. JAMA Oncology
- LBA9 IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC
- (2021) E. Felip et al. ANNALS OF ONCOLOGY
- Pairing smoking cessation with lung cancer screening may save lives
- (2021) Mike Fillon CA-A CANCER JOURNAL FOR CLINICIANS
- Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
- (2021) Keunchil Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Taletrectinib (AB-106; DS-6051b) in metastatic non-small cell lung cancer (NSCLC) patients with ROS1 fusion: Preliminary results of TRUST.
- (2021) Caicun Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary safety and efficacy results from phase 1 studies of DZD9008 in NSCLC patients with EGFR Exon20 insertion mutations.
- (2021) James Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
- (2021) Jonathan Spicer et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females
- (2021) Mindy C DeRouen et al. JNCI-Journal of the National Cancer Institute
- IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
- (2021) Mark A. Socinski et al. Journal of Thoracic Oncology
- Over-Time Risk of Lung Cancer Is Largely Owing to Continuing Smoking Exposition: A Good Reason to Quit
- (2021) Giuseppe Pelosi et al. Journal of Thoracic Oncology
- Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial
- (2021) Shun Lu et al. Journal of Thoracic Oncology
- Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
- (2021) Caicun Zhou et al. Journal of Thoracic Oncology
- Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
- (2021) Enriqueta Felip et al. LANCET
- Sotorasib for Lung Cancers with KRAS p.G12C Mutation
- (2021) Ferdinandos Skoulidis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
- (2021) Bob T. Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetically predicted insomnia and lung cancer risk: a Mendelian randomization study
- (2021) Zhenyu Huo et al. SLEEP MEDICINE
- Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
- (2021) Jianxing He et al. Lancet Respiratory Medicine
- Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
- (2021) Shun Lu et al. Lancet Respiratory Medicine
- Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer
- (2021) Leora Horn et al. JAMA Oncology
- Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer
- (2021) Salma K. Jabbour et al. JAMA Oncology
- MA02.01 Efficacy and Safety of Selpercatinib in Chinese Patients With RET Fusion-Positive Non-Small Cell Lung Cancer: A Phase 2 Trial
- (2021) S. Lu et al. Journal of Thoracic Oncology
- Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
- (2021) Shengxiang Ren et al. Journal of Thoracic Oncology
- MA02.02 Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer
- (2021) Q. Zhou et al. Journal of Thoracic Oncology
- IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
- (2021) Naoyuki Nogami et al. Journal of Thoracic Oncology
- MA13.08 CHOICE-01: A Phase 3 Study of Toripalimab Versus Placebo in Combination With First-Line Chemotherapy for Advanced NSCLC
- (2021) J. Wang et al. Journal of Thoracic Oncology
- Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
- (2021) Christian Rolfo et al. Journal of Thoracic Oncology
- Antibody-drug conjugates: A promising novel therapeutic approach in lung cancer
- (2021) Aakash Desai et al. LUNG CANCER
- Leukotriene inhibition and the risk of lung cancer among U.S. veterans with asthma
- (2021) S. Scott Sutton et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Excess Body Weight and Long-Term Incidence of Lung and Colon Cancer in Men; Follow-Up Study of 43 Years
- (2021) Yftach Gepner et al. International Journal of Environmental Research and Public Health
- Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer
- (2021) Caicun Zhou et al. JAMA Oncology
- Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients With EGFR Germline Mutations in a Large-Scale Retrospective Study
- (2021) Xinqing Lin et al. Frontiers in Oncology
- Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study
- (2021) Jie Zhang et al. Cancer Communications
- Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy
- (2021) Yawen Zheng et al. Cancer Communications
- Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
- (2021) Yi-Long Wu et al. Journal of Thoracic Oncology
- Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial
- (2021) Shun Lu et al. Journal of Thoracic Oncology
- Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
- (2020) Shugeng Gao et al. Journal of Thoracic Oncology
- Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
- (2020) Alexander Drilon et al. NATURE MEDICINE
- Polymorphisms and rare variants identified by next-generation sequencing confer risk for lung cancer in han Chinese population
- (2020) Xiaoqi Li et al. PATHOLOGY RESEARCH AND PRACTICE
- Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC).
- (2020) Justin F. Gainor et al. JOURNAL OF CLINICAL ONCOLOGY
- Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
- (2020) Paul K. Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multi-Level Cross Residual Network for Lung Nodule Classification
- (2020) Juan Lyu et al. SENSORS
- Multiclassifier fusion based on radiomics features for the prediction of benign and malignant primary pulmonary solid nodules
- (2020) Yao Shen et al. Annals of Translational Medicine
- Lung Cancer Occurrence—Correlation with Serum Chromium Levels and Genotypes
- (2020) Piotr Baszuk et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non–Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab
- (2020) Alexander Augustyn et al. Clinical Lung Cancer
- Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study
- (2020) Caicun Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Brigatinib Versus Crizotinib in Advanced ALK Inhibitor–Naive ALK-Positive Non–Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
- (2020) D. Ross Camidge et al. JOURNAL OF CLINICAL ONCOLOGY
- The Invasiveness Classification of Ground-Glass Nodules Using 3D Attention Network and HRCT
- (2020) Yangfan Ni et al. JOURNAL OF DIGITAL IMAGING
- The Regimen of Computed Tomography Screening for Lung Cancer
- (2020) Claudia I. Henschke et al. JOURNAL OF THORACIC IMAGING
- Efficacy and safety of sintilimab plus pemetrexed and platinum as first-line treatment for locally advanced or metastatic nonsquamous non-small cell lung cancer: a randomized, double-blind, phase 3 study (ORIENT-11)
- (2020) Yunpeng Yang et al. Journal of Thoracic Oncology
- The Effect of Advances in Lung-Cancer Treatment on Population Mortality
- (2020) Nadia Howlader et al. NEW ENGLAND JOURNAL OF MEDICINE
- Status of 10 targeted genes of non‐small cell lung cancer in eastern China: A study of 884 patients based on NGS in a single institution
- (2020) Dan Li et al. Thoracic Cancer
- Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients
- (2020) Si-Yang Liu et al. Biomarker Research
- Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations
- (2020) Michelle C. Turner et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lung Cancer in People’s Republic of China
- (2020) Shugeng Gao et al. Journal of Thoracic Oncology
- Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial
- (2020) James Chih-Hsin Yang et al. Journal of Thoracic Oncology
- Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
- (2020) Mariano Provencio et al. LANCET ONCOLOGY
- Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
- (2020) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer
- (2020) Yi-Long Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
- (2020) Jürgen Wolf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
- (2020) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The mortality of lung cancer attributable to smoking among adults in China and the United States during 1990–2017
- (2020) Xiaoxue Liu et al. Cancer Communications
- Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial
- (2020) M. Shi et al. ANNALS OF ONCOLOGY
- Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
- (2020) Wen-Zhao Zhong et al. JOURNAL OF CLINICAL ONCOLOGY
- First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
- (2020) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
- (2020) Caicun Zhou et al. Lancet Respiratory Medicine
- Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
- (2020) Wenhua Liang et al. Translational Lung Cancer Research
- Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
- (2019) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
- (2019) Martin Reck et al. Lancet Respiratory Medicine
- Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-positive Advanced Non-small-cell Lung Cancer in the Global Phase III ALEX Study
- (2019) D. Ross Camidge et al. Journal of Thoracic Oncology
- Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience
- (2019) Badi El Osta et al. Journal of Thoracic Oncology
- Elevated platelet count appears to be causally associated with increased risk of lung cancer: A Mendelian randomization analysis
- (2019) Ying Zhu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database
- (2019) Gaurav Singal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer
- (2019) Shun Lu et al. Journal of Thoracic Oncology
- K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways
- (2019) Matthias Scheffler et al. Journal of Thoracic Oncology
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- (2019) Tony S K Mok et al. LANCET
- Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study
- (2019) Yi-Long Wu et al. LUNG CANCER
- Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR , ALK , ROS1 , KRAS or BRAF
- (2019) Xibin Zhuang et al. Cancer Medicine
- Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
- (2019) Caicun Zhou et al. Lancet Respiratory Medicine
- Combination of icotinib and chemotherapy as first-line treatment for advanced lung adenocarcinoma in patients with sensitive EGFR mutations: A randomized controlled study
- (2019) Lisheng Xu et al. LUNG CANCER
- Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations
- (2019) Juncheng Dai et al. Lancet Respiratory Medicine
- Exposure to Welding Fumes, Hexavalent Chromium, or Nickel and Lung Cancer Risk
- (2019) Beate Pesch et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Pleural Plaques and the Risk of Lung Cancer in Asbestos-exposed Subjects
- (2019) Fraser JH Brims et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China
- (2019) Ruochuan Zang et al. ANNALS OF THORACIC SURGERY
- Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
- (2019) Alessandro Leonetti et al. BRITISH JOURNAL OF CANCER
- Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer
- (2019) Vanita Noronha et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study
- (2019) M. Dietel et al. LUNG CANCER
- The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population
- (2019) Birgit Guldhammer Skov et al. MODERN PATHOLOGY
- Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study
- (2019) Jingbo Liu et al. Translational Cancer Research
- Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
- (2019) Yukio Hosomi et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
- (2019) Suresh S. Ramalingam et al. NEW ENGLAND JOURNAL OF MEDICINE
- A manifold learning regularization approach to enhance 3D CT image-based lung nodule classification
- (2019) Ying Ren et al. International Journal of Computer Assisted Radiology and Surgery
- Short-term association between ambient air pollution and lung cancer mortality
- (2019) Ning Wang et al. ENVIRONMENTAL RESEARCH
- Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
- (2019) Yunpeng Yang et al. Lancet Respiratory Medicine
- Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study
- (2018) S Novello et al. ANNALS OF ONCOLOGY
- Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
- (2018) Yan Wang et al. BMC CANCER
- Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer
- (2018) Peter N. Morcos et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Adoption Rate of Video-Assisted Thoracic Surgery for Lung Cancer Varies Widely in China
- (2018) Jianqiao Cai et al. CHEST
- Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non–Small-Cell Lung Cancer
- (2018) Tudor Ciuleanu et al. Clinical Lung Cancer
- Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry
- (2018) Eleonora Bonaparte et al. Diagnostic Pathology
- Targeting EGFR in Lung Cancer: Current Standards and Developments
- (2018) Asunción Díaz-Serrano et al. DRUGS
- Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
- (2018) Bob T. Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer
- (2018) Yi-Long Wu et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
- (2018) Ming Sound Tsao et al. Journal of Thoracic Oncology
- Comparison of genetic profiles among primary lung tumor, metastatic lymph nodes and circulating tumor DNA in treatment-naïve advanced non-squamous non-small cell lung cancer patients
- (2018) Fangfang Xie et al. LUNG CANCER
- Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening
- (2018) Wenjia Yang et al. LUNG CANCER
- Radiomics analysis of pulmonary nodules in low-dose CT for early detection of lung cancer
- (2018) Wookjin Choi et al. MEDICAL PHYSICS
- Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
- (2018) Jacqulyne P. Robichaux et al. NATURE MEDICINE
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization
- (2018) Cecilia Mouronte-Roibás et al. RESPIRATION
- The link between chronic obstructive pulmonary disease phenotypes and histological subtypes of lung cancer: a case–control study
- (2018) Wei Wang et al. International Journal of Chronic Obstructive Pulmonary Disease
- Liquid biopsy for lung cancer early detection
- (2018) Mariacarmela Santarpia et al. Journal of Thoracic Disease
- Alectinib versus crizotinib in treatment-naïve anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study
- (2018) S Gadgeel et al. ANNALS OF ONCOLOGY
- Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer
- (2018) Yi-Long Wu et al. Journal of Thoracic Oncology
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
- (2018) Ying Cheng et al. Thoracic Cancer
- Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening
- (2018) Bruno Heleno et al. JAMA Internal Medicine
- Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial
- (2018) Dongsheng Yue et al. Lancet Respiratory Medicine
- Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer
- (2018) Baohui Han et al. JAMA Oncology
- Is high vitamin B12 status a cause of lung cancer?
- (2018) Anouar Fanidi et al. INTERNATIONAL JOURNAL OF CANCER
- SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer
- (2018) Nathan A. Pennell et al. JOURNAL OF CLINICAL ONCOLOGY
- The changing diagnostic pathway for lung cancer patients in Shanghai, China
- (2017) Tao Jiang et al. EUROPEAN JOURNAL OF CANCER
- Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
- (2017) Baohui Han et al. INTERNATIONAL JOURNAL OF CANCER
- Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
- (2017) James Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring ROS1 Rearrangement
- (2017) Sun Min Lim et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients
- (2017) Natalia Sutiman et al. Journal of Thoracic Oncology
- PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
- (2017) Fred R. Hirsch et al. Journal of Thoracic Oncology
- First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
- (2017) Jean-Charles Soria et al. LANCET
- Dabrafenib plus trametinib in patients with previously untreated BRAF V600E -mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
- (2017) David Planchard et al. LANCET ONCOLOGY
- Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
- (2017) Alice T Shaw et al. LANCET ONCOLOGY
- EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study
- (2017) Baohui Han et al. LUNG CANCER
- Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
- (2017) James D McKay et al. NATURE GENETICS
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Advent of Ultra-high Volume Thoracic Surgical Centers in Shanghai
- (2017) Alan D. L. Sihoe et al. WORLD JOURNAL OF SURGERY
- Using Deep Learning for Classification of Lung Nodules on Computed Tomography Images
- (2017) QingZeng Song et al. Journal of Healthcare Engineering
- Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer
- (2017) Lin Wang et al. Journal of Cancer
- Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer
- (2017) Yunjian Pan et al. Journal of Thoracic Disease
- Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases
- (2017) et al. JAMA Oncology
- Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015
- (2017) Ahmedin Jemal et al. JAMA Oncology
- The Management of Patients With Stage IIIA Non–Small Cell Lung Cancer With N2 Mediastinal Node Involvement
- (2017) Renato G. Martins et al. Journal of the National Comprehensive Cancer Network
- Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma
- (2017) Yuping Li et al. PLoS One
- Single nucleotide polymorphisms in DNA repair genes and putative cancer risk
- (2016) Beate Köberle et al. ARCHIVES OF TOXICOLOGY
- BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?
- (2016) Rafael Caparica et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Radiation exposure and lung disease in todayʼs nuclear world
- (2016) Steven D. Deas et al. CURRENT OPINION IN PULMONARY MEDICINE
- Particulate matter air pollution components and risk for lung cancer
- (2016) O. Raaschou-Nielsen et al. ENVIRONMENT INTERNATIONAL
- Estimation of heritability for nine common cancers using data from genome-wide association studies in Chinese population
- (2016) Juncheng Dai et al. INTERNATIONAL JOURNAL OF CANCER
- MassARRAY, pyrosequencing, and PNA clamping for EGFR mutation detection in lung cancer tissue and cytological samples: a multicenter study
- (2016) Kyueng-Whan Min et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations
- (2016) Ying Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2016) Suresh Senan et al. JOURNAL OF CLINICAL ONCOLOGY
- Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)
- (2016) Michael Kreuter et al. Journal of Thoracic Oncology
- New and emerging targeted treatments in advanced non-small-cell lung cancer
- (2016) Fred R Hirsch et al. LANCET
- Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations
- (2016) Claire Tissot et al. LUNG CANCER
- EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center
- (2016) Riccardo Giannini et al. ONCOLOGY REPORTS
- Ceritinib: a Review in ALK-Positive Advanced NSCLC
- (2016) Emma D. Deeks Targeted Oncology
- The short-term association between asthma hospitalisations, ambient temperature, other meteorological factors and air pollutants in Hong Kong: a time-series study
- (2016) Holly Ching-yu Lam et al. THORAX
- Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses
- (2016) Nikhil K. Khankari et al. PLOS MEDICINE
- Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis
- (2015) A. R. Vieira et al. ANNALS OF ONCOLOGY
- Lifestyle and Cancer Risk
- (2015) Verena A Katzke et al. CANCER JOURNAL
- Prevalence and clinicopathological characteristics of ALK fusion subtypes in lung adenocarcinomas from Chinese populations
- (2015) Difan Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04
- (2015) Jin Seok Ahn et al. JOURNAL OF CLINICAL ONCOLOGY
- BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Caicun Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Folate Receptor–Positive Circulating Tumor Cell Detected by LT-PCR–Based Method as a Diagnostic Biomarker for Non–Small-Cell Lung Cancer
- (2015) Xiaoxia Chen et al. Journal of Thoracic Oncology
- Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
- (2015) Luis Paz-Ares et al. LANCET ONCOLOGY
- Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients
- (2015) Rui Wang et al. Oncotarget
- Home kitchen ventilation, cooking fuels, and lung cancer risk in a prospective cohort of never smoking women in Shanghai, China
- (2014) Christopher Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012
- (2014) Marie Ng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Subclassification of pulmonary non-small cell lung carcinoma in fine needle aspirates using a limited immunohistochemistry panel
- (2014) Kusum Kapila et al. Journal of Cytology
- Stressful social relations and mortality: a prospective cohort study
- (2014) Rikke Lund et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Projected Outcomes Using Different Nodule Sizes to Define a Positive CT Lung Cancer Screening Examination
- (2014) David S. Gierada et al. JNCI-Journal of the National Cancer Institute
- Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations
- (2014) Adi Gazdar et al. Journal of Thoracic Oncology
- A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
- (2014) Yuankai Shi et al. Journal of Thoracic Oncology
- Cisplatin versus Carboplatin-Based Regimens for the Treatment of Patients with Metastatic Lung Cancer. An Analysis of Veterans Health Administration Data
- (2014) Rafael Santana-Davila et al. Journal of Thoracic Oncology
- Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
- (2014) LANCET
- Epidemiology: The dominant malignancy
- (2014) Eric Bender NATURE
- Acquired resistance to TKIs in solid tumours: learning from lung cancer
- (2014) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Folate Receptor-Positive Circulating Tumor Cells as a Novel Diagnostic Biomarker in Non-Small Cell Lung Cancer
- (2014) Yue Yu et al. Translational Oncology
- Histological subtypes of lung cancer in Chinese women from 2000 to 2012
- (2014) Xiao Nong Zou et al. Thoracic Cancer
- Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
- (2014) Edward F. Patz et al. JAMA Internal Medicine
- KIF5B-RETfusions in Chinese patients with non-small cell lung cancer
- (2013) Weijing Cai et al. CANCER
- The use of stained cytologic direct smears forALKgene rearrangement analysis of lung adenocarcinoma
- (2013) Bryan L. Betz et al. CANCER CYTOPATHOLOGY
- Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung cancer? A systematic review and meta-analysis
- (2013) Zhenrong Zhang et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Kurtosis and skewness assessments of solid lung nodule density histograms: differentiating malignant from benign nodules on CT
- (2013) Ayano Kamiya et al. JAPANESE JOURNAL OF RADIOLOGY
- Preselection Based on Clinical Characteristics in German Non–Small-Cell Lung Cancer Patients Screened for EML4-ALK Translocation
- (2013) Amanda Laura Helen Tufman et al. Journal of Thoracic Oncology
- A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer
- (2013) Miklos Pless et al. LUNG CANCER
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
- (2013) Jonathan M. Ostrem et al. NATURE
- Time to ESCAPE the city? Air pollution linked to lung cancer
- (2013) Bryony Jones Nature Reviews Clinical Oncology
- Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR
- (2013) Jiatao Lou et al. PLoS One
- Subclassification of Non-Small Cell Lung Cancer by Cytologic Sampling: A Logical Approach with Selective Use of Immunocytochemistry
- (2012) Hillary Z. Kimbrell et al. ACTA CYTOLOGICA
- Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study
- (2012) M. Kreuter et al. ANNALS OF ONCOLOGY
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel Mass Spectrometry–Based Assay for Diagnosis of EML4-ALK–Positive Non–Small Cell Lung Cancer
- (2012) Kazuko Sakai et al. Journal of Thoracic Oncology
- Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys
- (2012) Gary A Giovino et al. LANCET
- Radiomics: the process and the challenges
- (2012) Virendra Kumar et al. MAGNETIC RESONANCE IMAGING
- Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population
- (2012) Jing Dong et al. NATURE GENETICS
- Association between Chronic Obstructive Pulmonary Disease and Lung Cancer: A Case-Control Study in Southern Chinese and a Meta-Analysis
- (2012) Hui Wang et al. PLoS One
- Effect of the Interaction Between Outdoor Air Pollution and Extreme Temperature on Daily Mortality in Shanghai, China
- (2011) Yuexin Cheng et al. JOURNAL OF EPIDEMIOLOGY
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410
- (2011) W. J. Curran et al. JNCI-Journal of the National Cancer Institute
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese
- (2011) Zhibin Hu et al. NATURE GENETICS
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Global Patterns of Cancer Incidence and Mortality Rates and Trends
- (2010) A. Jemal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial
- (2010) Katherine M.W. Pisters et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer
- (2010) Enriqueta Felip et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
- (2010) Anne Aupérin et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer Risks After Radiation Exposure in Middle Age
- (2010) I. Shuryak et al. JNCI-Journal of the National Cancer Institute
- Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database
- (2010) Subroto Paul et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression
- (2010) Xuchao Zhang et al. Molecular Cancer
- Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene
- (2009) Tsuyoshi Takahashi et al. ANNALS OF SURGICAL ONCOLOGY
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- (2009) Alice T. Shaw et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10
- (2009) Charles A. Butts et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer
- (2009) Rodrigo Arriagada et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymph Node Dissection for Lung Cancer: Significance, Strategy, and Technique
- (2009) Shun-ichi Watanabe et al. Journal of Thoracic Oncology
- Plasma DNA Quantification in Lung Cancer Computed Tomography Screening
- (2008) Gabriella Sozzi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
- (2008) J. P. Koivunen et al. CLINICAL CANCER RESEARCH
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
- (2008) Jean-Pierre Pignon et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
- (2008) Gary M. Strauss et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started